Publication | Closed Access

Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression

UrologyHigh-risk Prostate CancerGenitourinary CancerMedicinePathologyMalignant ProgressionProstatic DiseaseOncologyTumor Microenvironment